1. Home
  2. ERII vs PROK Comparison

ERII vs PROK Comparison

Compare ERII & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

N/A

Current Price

$7.22

Market Cap

400.7M

Sector

Technology

ML Signal

N/A

Logo ProKidney Corp.

PROK

ProKidney Corp.

N/A

Current Price

$1.05

Market Cap

359.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERII
PROK
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.7M
359.4M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
ERII
PROK
Price
$7.22
$1.05
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$7.50
★ $7.88
AVG Volume (30 Days)
873.2K
★ 1.3M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.00
N/A
EPS
N/A
★ N/A
Revenue
★ $134,987,000.00
$893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$44.10
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 1075.00
52 Week Low
$6.25
$0.87
52 Week High
$16.30
$2.65

Technical Indicators

Market Signals
Indicator
ERII
PROK
Relative Strength Index (RSI) 55.73 33.21
Support Level $6.40 $0.87
Resistance Level $9.18 $2.01
Average True Range (ATR) 0.30 0.15
MACD 0.04 -0.01
Stochastic Oscillator 67.35 23.43

Price Performance

Historical Comparison
ERII
PROK

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: